D. Kumar

发表

Food hypersensitivity and irritable bowel syndrome

M. Benson, M. Benson, S. Zar, 2001, Alimentary pharmacology & therapeutics.

Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs

D. Rampton, D. Evans, S. Nugent, 2001, Gut.

Pathogenesis of gall stones in Crohn's disease: an alternative explanation.

R. Hutchinson, P. Tyrrell, D. Kumar, 1994, Gut.

Bloating in functional bowel disorders

M. Benson, S. Zar, D. Kumar, 2002 .

Bile composition in inflammatory bowel disease: ileal disease and colectomy, but not colitis, induce lithogenic bile

S. Pereira, R. Dowling, D. Kumar, 2003, Alimentary pharmacology & therapeutics.

Systematic review of postoperative complications in patients with inflammatory bowel disease treated with immunomodulators

R. Pollok, V. Subramanian, D. Kumar, 2006, The British journal of surgery.

Crohn's disease and ulcerative colitis: divergent trends in hospital admission rates 1989/90 to 1999/2000

A. Majeed, J. Maxwell, D. Kumar, 2002 .

Antibiotics increase functional abdominal symptoms

M. Mendall, Devinder Kumar, E. Rink, 2002, American Journal of Gastroenterology.

Antibiotic use, childhood affluence and irritable bowel syndrome (IBS)

M. Mendall, D. Kumar, Davinder Kumar, 1998, European journal of gastroenterology & hepatology.

Irritable bowel syndrome

D. Kumar, M. Mendall, P. Maxwell, 1997, The Lancet.

Diverticular disease of the colon: ethnic differences in frequency

P. Neild, M. Benson, J. Maxwell, 2004, Alimentary pharmacology & therapeutics.

3 Nutrition in Inflammatory Bowel Disease

D. Kumar, 1993 .

Nutrition in Inflammatory Bowel Disease

D. Kumar, 1993 .

Management of Cancer and Dysplasia in Ulcerative Colitis

D. Kumar, 1993 .

Ulcerative Colitis: Indications for Surgical Intervention

D. Kumar, 1993 .

Guidelines on the irritable bowel syndrome: mechanisms and practical management

R Jones, Q Aziz, P. Whorwell, 2007, Gut.

Review article: bloating in functional bowel disorders.

M. Benson, S. Zar, D. Kumar, 2002, Alimentary pharmacology & therapeutics.

British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome

P. Whorwell, R. Spiller, A. Forbes, 2000, Gut.

Biliary lactoferrin concentrations are increased in active inflammatory bowel disease: a factor in the pathogenesis of primary sclerosing cholangitis?

S. Pereira, J. Rhodes, R. Dowling, 1998, Clinical science.

Systematic review: adipose tissue, obesity and gastrointestinal diseases

M. Mendall, Devinder Kumar, D. Kumar, 2006, Alimentary pharmacology & therapeutics.

Food‐specific IgG4‐guided exclusion diets improve symptoms in Crohn’s disease: a pilot study

Devinder Kumar, D. Kumar, N. Rajendran, 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Purulent myositis of the thigh as a presentation of perforated low rectal cancer.

J. Steinke, D. Kumar, N. Rajendran, 2018, Annals of the Royal College of Surgeons of England.

Role of food hypersensitivity in irritable bowel syndrome.

S. Zar, D. Kumar, 2002, Minerva medica.

Allergic colitis presenting in the first day of life: report of three cases.

G. Chelimsky, J. Wyatt-Ashmead, D. Kumar, 2000, Journal of pediatric gastroenterology and nutrition.

Adipokines and gastrointestinal disease: authors’ reply

A. Abulafi, M. Mendall, Devinder Kumar, 2006 .

A CRITICAL REVIEW ON CURRENT THERAPY ON ULCERATIVE COLITIS

P. Venkatesh, D. Kumar, C. Saritha, 2017 .